545396-52-9

Basic information

• Product Name: 4-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE 1-OXIDE
• Synonyms: 4-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE 1-OXIDE;1-oxido-4-[4-(trifluoromethyl)phenyl]pyridin-1-ium
• CAS NO: 545396-52-9
• Molecular Formula: C₁₂H₈F₃NO
• Molecular Weight: 239.19
• Mol File: 545396-52-9.mol
• Article Data: 9

Chemical Properties

• Boiling Point: 385.2±42.0 °C(Predicted)
• Appearance: /
• Density: 1.25±0.1 g/cm3(Predicted)
• PKA: 0.29±0.10(Predicted)
• CAS DataBase Reference: 4-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE 1-OXIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE 1-OXIDE(545396-52-9)
• EPA Substance Registry System: 4-(4-TRIFLUOROMETHYLPHENYL)PYRIDINE 1-OXIDE(545396-52-9)

Safety Data

• Hazardous Substances Data: 545396-52-9(Hazardous Substances Data)

Upstream product

• 128796-39-4 4-trifluoromethylphenylboronic acid 
• 1121-76-2 4-chloropyridine N-oxide 
• 942947-09-3 2-(benzyloxy)-4-(4-(trifluoromethyl)phenyl)pyridine 
• 220000-88-4 4-(4-trifluoromethyl-phenyl)-pyridine 

Downstream Products

• 545396-52-9 4-(4-(trifluoromethyl)phenyl)pyridin-2(1H)-one 
• 1108184-01-5 1-(3-methyl-4-nitrophenyl)-4-(4-(trifluoromethyl)phenyl)pyridin-2(1H)-one 
• 1108183-98-7 1-(1-(2,2-Dimethoxyethyl)-1H-indazol-5-yl)-4-(4-(trifluoromethyl)phenyl)pyridin-2(1H)-one 
• 1108183-76-1 (+)-1-(1-(2-((1S,4S)-2-Oxa-5-azabicyclo[2.2.1]heptan-5-yl)ethyl)-1H-indazol-5-yl)-4-(4-(trifluoromethyl)phenyl)pyridin-2(1H)-one hydrochloride 
• 1173157-02-2 tert-butyl 7-(2-oxo-4-(4-(trifluoromethyl)phenyl)pyridin-1(2H)-yl)-9-tosyl-3,4-dihydro-1H-pyrido[3,4-b]indole-2(9H)-carboxylate 
• 1260492-90-7 C₂₄H₂₀F₃N₃O 
• 1260494-08-3 tert-butyl 6-methyl-8-(2-oxo-4(4-trifuoromethyl)phenyl)pyridine-1(2H)-yl-3,4,5,6-tetrahydroazepino[4,3-b]indole-2(1H)-carboxylate 
• 1260491-91-5 1-(6-methyl-1,2,3,4,5,6-hexahydroazepino[4,3-b]indol-8-yl)-4((4-trifluoromethyl)phenyl)pyridin-2(1H)-one hydrochloride 
• 1260494-26-5 tert-butyl 6-methyl-8-(2-oxo-4(4-trifuoromethyl)phenyl)pyridin-1(2H)-yl-1,2,4,5-tetrahydroazepino[4,5-b]indole-3(6H)-carboxylate 
• 1260492-06-5 1-(6-methyl-1,2,3,4,5,6-hexahydroazepino[4,5-b]indol-8-yl)-(4(4-trifluoromethyl)phenyl)pyridin-2(1H)-one hydrochloride 
• 1613400-10-4 1-(1,2,3,4-tetrahydrobenzofuro[3,2-c]pyridin-7-yl)-4-(4-(trifluoromethyl)phenyl)pyridin-2(1H)-one 
• 1613401-44-7 tert-butyl 7-(2-oxo-4-(4-(trifluoromethyl)phenyl)pyridin-1(2H)-yl)-3,4-dihydrobenzofuro[3,2-c]pyridine-2(1H)-carboxylate 
• 1613399-89-5 1-(2,3,4,5-Tetrahydro-1H-benzofuro[3,2-c]azepin-8-yl)-4-(4-(trifluoromethyl)phenyl)pyridin-2(1H)-one 
• 1613401-11-8 tert-butyl 8-(2-oxo-4-(4-(trifluoromethyl)phenyl)pyridin-1(2H)-yl)-4,5-dihydro-1H-benzofuro[3,2-c]azepine-2(3H)-carboxylate 

Relevant articles and documents

TETRAHYDRO-AZACARBOLINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USES THEREOF

The present invention relates to tetrahydro-azacarboline derivatives of formula (I): having the substituents as described herein which are melanin-concentrating hormone (MCH-1) receptor antagonists. The present invention also relates to pharmaceutical com

AZINONE-SUBSTITUTED AZAPOLYCYCLE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF

Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are als

(1-AZINONE) -SUBSTITUTED PYRIDOINDOLES AS MCH ANTAGONISTS

Substituted pyridoindoles for incorporation in pharmaceutical compositions employed in the treatment of various diseases correspond to formula (I) wherein R1 is H or optionally substituted alkyl; R2, R3, R4 are